Description: Methylprednisolone 4 mg/5 mL Oral Liquid is a specially compounded medication designed for oral use, offering a precise and manageable method of drug delivery. This formulation is particularly beneficial for patients who experience difficulty swallowing pills, such as children and the elderly. The liquid form ensures accurate dosing and ease of administration. It is also used in the management of adrenal insufficiency and to suppress the immune system following organ transplantation.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Methylprednisolone 4 mg/5 mL Oral Liquid is a corticosteroid medication specifically compounded for ease of administration and precise dosing. This oral liquid formulation is designed to provide a convenient alternative to tablet or injectable forms, particularly beneficial for patients who have difficulty swallowing pills, such as children and the elderly. The liquid form allows for flexible dosing, which can be adjusted according to the specific needs of the patient.
Methylprednisolone is a potent anti-inflammatory and immunosuppressive agent. It works by mimicking the effects of cortisol, a naturally occurring hormone produced by the adrenal glands, which modulates the body's inflammatory response. By doing so, it reduces inflammation and alters the immune system's activity. It is also used to prevent organ rejection in transplant patients.
The efficacy of Methylprednisolone 4 mg/5 mL Oral Liquid depends on its proper use and adherence to the prescribed dosage regimen. It is crucial for prescribers to tailor the dosing schedule to the individual patient's condition and response to therapy, as well as to monitor for potential side effects, which can include immune suppression, fluid retention, hypertension, mood swings, and increased blood sugar levels, among others. Patients should be counseled on the importance of following their dosing schedule and not to discontinue the medication abruptly to avoid withdrawal symptoms and exacerbation of their condition.
Bayview Pharmacy's team of compounding pharmacists ensures that each batch of Methylprednisolone 4 mg/5 mL Oral Liquid is prepared to the highest standards of quality and consistency. For any questions regarding this formulation, its uses, or any other concerns, please do not hesitate to reach out to us for professional advice and support.
Methylprednisolone is a corticosteroid medication used to reduce inflammation and suppress the immune system in various conditions such as allergic reactions, asthma, rheumatoid arthritis, and certain autoimmune diseases. When considering the use of methylprednisolone 4 mg/5 mL oral liquid, it is important to be aware of potential drug interactions that may affect the efficacy of the medication or increase the risk of adverse effects.
One significant interaction is with CYP3A4 inducers and inhibitors. Methylprednisolone is metabolized by the CYP3A4 enzyme. Drugs that induce CYP3A4, such as phenytoin, carbamazepine, rifampin, and certain barbiturates, can decrease the plasma concentration of methylprednisolone, potentially reducing its effectiveness. Conversely, CYP3A4 inhibitors like ketoconazole, itraconazole, and erythromycin may increase the plasma concentration of methylprednisolone, leading to an increased risk of side effects.
Concomitant use of nonsteroidal anti-inflammatory drugs (NSAIDs) with methylprednisolone may increase the risk of gastrointestinal ulceration or bleeding. Patients should be monitored for signs of gastrointestinal distress and bleeding, especially if they have a history of ulcer disease or are taking higher doses of methylprednisolone.
Live vaccines should be used with caution in patients receiving immunosuppressive doses of methylprednisolone, as the desired immune response may not be achieved, and there is a potential risk of infection from the vaccine. It is advisable to consult with a healthcare provider before receiving any vaccinations.
Diabetes medications may require adjustment when taken with methylprednisolone, as corticosteroids can increase blood glucose levels. Monitoring of blood glucose and adjustment of antidiabetic medication dosage may be necessary to maintain adequate glycemic control.
Patients on anticoagulant therapy, such as warfarin, should be closely monitored as methylprednisolone may alter the anticoagulant effect, potentially necessitating a dosage adjustment of the anticoagulant medication.
Additionally, methylprednisolone can interact with other medications such as diuretics, leading to electrolyte imbalances, and with medications that can cause potassium depletion, increasing the risk of hypokalemia. It is also important to monitor patients on cardiac glycosides, like digoxin, as hypokalemia can potentiate the effects of these drugs.
It is essential for patients and prescribers to be aware of these and other potential drug interactions when considering the use of methylprednisolone oral liquid. This is not an exhaustive list, and other interactions may exist. Patients should be advised to inform their healthcare provider of all medications, supplements, and herbal products they are taking. For any questions or concerns regarding drug interactions with methylprednisolone, please reach out to us at Bayview Pharmacy for further assistance.
Methylprednisolone is a corticosteroid medication that works by mimicking the effects of cortisol, a naturally occurring hormone produced by the adrenal glands. Cortisol is essential for various bodily functions, including the suppression of inflammation, regulation of metabolism, and modulation of the immune system. In the 4 mg/5 mL oral liquid formulation, methylprednisolone is dissolved in a suitable vehicle to create a homogenous solution that ensures accurate dosing and ease of administration.
When ingested, methylprednisolone is absorbed into the bloodstream through the gastrointestinal tract. Once absorbed, it exerts its anti-inflammatory and immunosuppressive effects by entering cells and binding to glucocorticoid receptors. This binding leads to the modification of the transcription of certain genes, particularly those involved in inflammatory and immune responses. By doing so, methylprednisolone decreases the production of inflammatory chemicals and inhibits the accumulation of inflammatory cells at sites of inflammation.
These include conditions such as rheumatoid arthritis, lupus, asthma, allergic reactions, and certain types of cancer. The medication helps to alleviate symptoms such as swelling, redness, pain, and allergic reactions. Additionally, in diseases where the immune system attacks the body's own tissues, known as autoimmune diseases, methylprednisolone can help to reduce the immune system's harmful activity.
The oral liquid formulation is particularly beneficial for patients who have difficulty swallowing pills, such as young children, the elderly, or those with dysphagia. The liquid form allows for flexible dosing, which can be precisely measured with a syringe or dropper, ensuring that patients receive the exact amount of medication prescribed by their healthcare provider. Moreover, the liquid can be flavored to mask the taste of the medication, improving patient compliance.
Therefore, it should be used under the guidance of a healthcare professional, and patients should be monitored regularly. If you have any questions or require further information about the methylprednisolone 4 mg/5 mL oral liquid formulation, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to support you with expert advice and personalized care.
This is a specially compounded liquid medication that is taken by mouth to deliver a precise dose of Methylprednisolone. The concentration is 4 mg of the active medication in every 5 mL of the liquid. It is designed for patients who have difficulty swallowing solid forms of medication, such as tablets or capsules.
Patients may be prescribed this liquid form if they have difficulty swallowing pills, which can include young children, older adults, or anyone with dysphagia or an impaired gag reflex. Liquid forms can also allow for dose adjustment easily.
The liquid should be stored in a cool, dry place away from light and moisture. The storage instructions may vary, so please check the label or ask your pharmacist for the specific storage requirements for your medication.
Yes, the liquid form allows healthcare providers to adjust the dose as needed. However, any dose adjustment should be made under the guidance of a healthcare provider and based on the patient's medical condition and response to treatment.
Yes, this form can be suitable for children as long as the dosage is correctly adjusted for their age and weight by a healthcare professional. It is particularly beneficial for children who cannot swallow pills.
It is important to follow the doctor's instructions on how to take this medication. Shake the bottle well before each dose, and use a proper measuring device to ensure the correct amount is given. Do not use household spoons, as they may not provide an accurate dose.
In some cases, mixing the medication with a small amount of soft food or a drink might be acceptable to improve palatability. However, you should consult with your healthcare provider before doing so to ensure that it does not affect the efficacy or absorption of the medication.
If you miss a dose, take it as soon as you remember. If it is near the time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double up on doses to make up for a missed one.
Like all medications, Methylprednisolone can cause side effects. Common side effects include nausea, vomiting, heartburn, headache, dizziness, trouble sleeping, increased appetite, or weight gain. If any of these effects persist or worsen, contact your doctor or pharmacist promptly.
Methylprednisolone Oral Liquid is a prescription medication that contains a corticosteroid, which is an anti-inflammatory drug. It is specifically formulated and prescribed by a healthcare provider to treat certain medical conditions. Over-the-counter liquid medications typically do not contain corticosteroids and are used for different, often less serious, health issues.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally